News

SS Innovations Completes Financial Audit and Uplisting Plans

SS Innovations Completes Financial Audit and Uplisting Plans

Completion of BDO Audit Process by SS Innovations

SS Innovations International, Inc. (OTC: SSII) is making significant strides towards growth in the healthcare technology sector. Recently, the company announced that BDO India LLP has finalized the re-audit of its consolidated financial statements. This process validated the financial accuracy of the years ending December 31, 2023, and 2022, highlighted in their previously filed Annual Report. This essential audit is a vital step as the company navigates its journey towards NASDAQ uplisting, making its stock more accessible to a larger pool of investors.

Transitioning to BDO Following SEC Developments

In a notable turn of events, SS Innovations terminated its prior accounting firm, BF Borgers CPA PC, following an SEC order prohibiting their practice. This decision was not taken lightly as it had implications for several public entities. In response, the company engaged BDO for an in-depth re-evaluation of its previously filed financials. This re-audit aimed to ensure transparency and accuracy in the financial data presented to shareholders and the market at large.

Uncovering Material Errors

During the re-audit, SS Innovations identified material discrepancies in its past financial statements. These errors necessitated a restatement of the financial reports prepared for the year ending December 31, 2023. Updated reports were filed to the SEC, highlighting significant changes in the company's financial standing.

Highlighting Major Financial Changes

Among the critical revisions were adjustments in shareholders' equity and working capital surplus. The company reported an increase in shareholders' equity from $14.30 million to $19.72 million, while working capital surplus rose by $3.85 million. Such improvements mark a solid financial foundation for the company as it prepares for its next major step.

Pathway to NASDAQ Uplisting

SS Innovations is poised to uplist its common stock to NASDAQ, bypassing the need for a pending Registration Statement on Form S-1. The company believes that it now meets all listing requirements for this advancement. The management team sees this transition as a unique opportunity to engage a broader community of investors and surge forward in its mission.

Expanding Robotic Surgery Footprint

By successfully completing over 2,500 robotic surgical operations, primarily in India, SS Innovations has firmly established its presence in the robotic surgery sector. Particularly noteworthy is its expansion into Indonesia, where the company conducted its first robotic cardiac surgery. Such achievements underline the effectiveness and reliability of the SSi Mantra surgical system, showcasing the potential for future growth in global markets.

About SS Innovations

Dedicated to innovation, SS Innovations International, Inc. is a pioneer in developing surgical robotic systems, focusing on affordability and accessibility. The SSi Mantra surgical system is at the heart of their operations, catering to various surgical specialties including cardiac surgery. With operations based in India, SS Innovations is committed to extending its reach globally, empowering healthcare providers and enhancing patient outcomes.

Frequently Asked Questions

What is the significance of the BDO audit completion?

The completion of the BDO audit is crucial for SS Innovations as it ensures the accuracy of financial statements and facilitates the company's NASDAQ uplisting process.

What prompted the change from Borgers to BDO as the accounting firm?

The SEC's order barring Borgers from practice led SS Innovations to seek a new independent registered public accounting firm, resulting in the engagement of BDO.

How will the financial restatement affect shareholders?

The restatement will provide shareholders with a clearer and more reliable picture of the company's financial health, ultimately fostering more confidence among investors.

What is the SSi Mantra system?

The SSi Mantra is a sophisticated modular surgical robotic system designed to enhance the efficiency and effectiveness of surgical procedures, making robotic surgery more widely accessible.

What are SS Innovations' plans for future growth?

SS Innovations aims to expand its operations internationally, with a focus on completing additional robotic surgical procedures and enhancing its presence in global markets.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 219

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 365

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 468

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Affordable Technology Solutions with Human-I-T's Initiative

Updated Category News Views 184

Human-I-T Launches 'Get It Done' Initiative to Bridge Digital Divide Human-I-T has unveiled its new 'Get It Done' Initiative aimed at making essential technology accessible to everyone without straining their finances. This program focuses on providing quality refurbished laptops at an affordable price, ensuring that individuals and families can benefit from reliable...

Continue Reading
Jasper Street Launches Activism Defense Practice with New Partners

Updated Category News Views 125

Jasper Street Partners Strengthens Activism Defense Practice Jasper Street Partners is gearing up to enhance its defense against activist investors by bringing on board two experienced bankers. Their main objective is clear: to assist clients in identifying weaknesses, navigating proxy contests, and managing the pressures that come with public activism. Introducing New...

Continue Reading
Royalty Pharma's $300 Million Partnership with Zenas BioPharma

Updated Category News Views 139

Funding Agreement for Obexelimab Development Royalty Pharma plc and Zenas BioPharma, Inc. have joined forces in a groundbreaking funding agreement that could inject up to $300 million into the development of obexelimab, a promising treatment for autoimmune diseases, specifically IgG4-Related Disease (IgG4-RD). This alliance highlights Royalty Pharma’s commitment to...

Continue Reading
KBR, Inc. Shares Drop Significantly Following Contract News

Updated Category News Views 242

Significant Decline in KBR, Inc. Shares KBR, Inc. (NYSE: KBR) recently faced a substantial decline in its stock value. This shift came after the announcement regarding the termination of a key contract, leaving many investors anxious about the company's future prospects. The market reacted sharply, indicating the level of uncertainty surrounding KBR's operations and...

Continue Reading
Dr. Mike Varshavski to Address Medical Misinformation Soon

Updated Category News Views 407

Dr. Mike Varshavski to Discuss Medical Misinformation The National Press Club is set to host a compelling event featuring Dr. Mikhail "Dr. Mike" Varshavski, a well-known physician and a social media phenomenon. This exciting Headliners event will take place soon, and attendees can expect an engaging dialogue focused on vital issues surrounding medical misinformation and...

Continue Reading